Interestingly, there was no strong relationship between the syndecan-1 levels and blood pressure (Supplementary Table 1), vascular access (Supplementary Table 2), cardiovascular disease (Supplementary Table 3), and primary disease (Supplementary Table 4) before and after dialysis. Here, SDC1 is linked to cardiovascular disorder.